Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients | MicrobiomeTrials← Back to trialsNCT05637216
Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2023-08-17Est. Completion: 2027-08-17
Enrollment target: 43 participants Locations- Vail Health Shaw Cancer Center, Edwards, Colorado, United States
Other microbiome trials you might be interested in
Non-Small Cell Lung CancerRadiation Induced Lung Injury (RILI)
Currently, the standard of care treatment for newly diagnosed, inoperable stage III non-small cell lung cancer is radiot…
Toronto, CanadaEst. completion Nov 30, 2031
Liver FibrosisSteatohepatitisElevated Transaminases
This study will provide a basis for research on the impact of liver injury caused by antiretroviral therapy in HIV-infec…
Bethesda, United States